• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[序贯尼莫地平-还原型谷胱甘肽治疗酒精戒断综合征。初步经验]

[Sequential nimodipine-reduced glutathione treatment in alcoholic abstinence syndrome. Preliminary experience].

作者信息

Gatti A, Munari L, Perretti A, Porta M, Altamura C, Ragazzetti M G

机构信息

Divisione di Neurologia, Policlinico San Marco, Zingonia, Bergamo.

出版信息

Minerva Med. 1992 May;83(5):277-81.

PMID:1589132
Abstract

Alcohol abstinence syndrome (AAS) occurs in alcohol dependent patients a few hours after ceasing to drink, first in the form of gastrointestinal and dysvegetative signs, then with the involvement of neurological functions. The results obtained in 15 patients selected according to DSM III criteria, treated with nimodipine (calcium entry blocker) in the acute phase and with reduced glutathione in the subacute phase are presented. All patients who, during treatment, did not take other drugs, showed a definite, fast improvement in symptoms, especially in neurovegetative symptoms. Administration of nimodipine, which seems capable of reducing the catecholaminergic drive, was very well tolerated. Treatment with reduced glutathione is justified by the fact that the inadequate intake of alcohol is responsible for liver changes and, particularly, for a significant reduction in liver levels of glutathione, a condition that makes the cell more exposed to attack on the part of substances that activate lipoperoxidation processes. The results obtained seem to confirm a protective action on the part of reduced glutathione.

摘要

酒精戒断综合征(AAS)发生在酒精依赖患者停止饮酒后的数小时内,最初表现为胃肠道和自主神经功能紊乱症状,随后累及神经功能。本文呈现了根据《精神疾病诊断与统计手册》第三版(DSM III)标准选取的15例患者的治疗结果,这些患者在急性期接受尼莫地平(钙通道阻滞剂)治疗,亚急性期接受还原型谷胱甘肽治疗。所有在治疗期间未服用其他药物的患者,症状均有明确且快速的改善,尤其是神经自主症状。尼莫地平似乎能够降低儿茶酚胺能驱动力,其耐受性良好。使用还原型谷胱甘肽进行治疗的依据是,酒精摄入不足会导致肝脏变化,特别是肝脏中谷胱甘肽水平显著降低,这种情况会使细胞更容易受到激活脂质过氧化过程的物质的攻击。所获得的结果似乎证实了还原型谷胱甘肽具有保护作用。

相似文献

1
[Sequential nimodipine-reduced glutathione treatment in alcoholic abstinence syndrome. Preliminary experience].[序贯尼莫地平-还原型谷胱甘肽治疗酒精戒断综合征。初步经验]
Minerva Med. 1992 May;83(5):277-81.
2
Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase.戒酒前使用尼莫地平可预防戒酒期的记忆缺陷。
Neuroscience. 2008 Nov 19;157(2):376-84. doi: 10.1016/j.neuroscience.2008.09.010. Epub 2008 Sep 11.
3
[Correction of the symptoms of late substance withdrawal syndrome by intra-conjunctival administration of 5% homatropine solution (preliminary report)].
Psychiatr Pol. 1990 May-Jun;24(3):195-201.
4
Nimodipine in human alcohol withdrawal syndrome--an open study.
Eur Neuropsychopharmacol. 1990 Nov;1(1):37-40. doi: 10.1016/0924-977x(90)90008-x.
5
Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat.尼莫地平,一种二氢吡啶类钙通道阻滞剂,可预防大鼠因长期胃内乙醇暴露引起的酒精性肝炎。
Hepatology. 1996 Aug;24(2):391-7. doi: 10.1002/hep.510240217.
6
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.巴氯芬减少酒精渴望和摄入量的能力:II——初步临床证据。
Alcohol Clin Exp Res. 2000 Jan;24(1):67-71.
7
Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome.劳拉西泮与氯氮䓬治疗急性酒精戒断综合征的双盲比较
Clin Ther. 1983;6(1):52-8.
8
[Effect of phenazepam on the nocturnal sleep of patients with the alcoholic abstinence syndrome].[芬那西泮对酒精戒断综合征患者夜间睡眠的影响]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(2):263-6.
9
Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.氯美噻唑或安慰剂用于酒精依赖患者戒断期的多导睡眠图——一项双盲随机研究
Pharmacopsychiatry. 2004 Sep;37(5):228-35. doi: 10.1055/s-2004-832597.
10
Use of nimodipine in the medical treatment of Menière's disease: clinical experience.尼莫地平在梅尼埃病药物治疗中的应用:临床经验
Am J Otol. 1996 Jul;17(4):577-80.